Display options
Cite
Manic G, Musella M, Corradi F, et al. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell Death Differ. 2021;28(7):2060-2082doi: 10.1038/s41418-020-00733-4.
Manic, G., Musella, M., Corradi, F., Sistigu, A., Vitale, S., Soliman Abdel Rehim, S., Mattiello, L., Malacaria, E., Galassi, C., Signore, M., Pallocca, M., Scalera, S., Goeman, F., De Nicola, F., Guarracino, A., Pennisi, R., Antonangeli, F., Sperati, F., Baiocchi, M., Biffoni, M., Fanciulli, M., Maugeri-Saccà, M., Franchitto, A., Pichierri, P., De Maria, R., & Vitale, I. (2021). Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell death and differentiation, 28(7), 2060-2082. https://doi.org/10.1038/s41418-020-00733-4
Manic, Gwenola, et al. "Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51." Cell death and differentiation vol. 28,7 (2021): 2060-2082. doi: https://doi.org/10.1038/s41418-020-00733-4
Manic G, Musella M, Corradi F, Sistigu A, Vitale S, Soliman Abdel Rehim S, Mattiello L, Malacaria E, Galassi C, Signore M, Pallocca M, Scalera S, Goeman F, De Nicola F, Guarracino A, Pennisi R, Antonangeli F, Sperati F, Baiocchi M, Biffoni M, Fanciulli M, Maugeri-Saccà M, Franchitto A, Pichierri P, De Maria R, Vitale I. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell Death Differ. 2021 Jul;28(7):2060-2082. doi: 10.1038/s41418-020-00733-4. Epub 2021 Feb 02. PMID: 33531658; PMCID: PMC8257675.
Copy Download .nbib Format: NLM
Share it on

Cell Death Differ. 2021 Jul;28(7):2060-2082. doi: 10.1038/s41418-020-00733-4. Epub 2021 Feb 02.

Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.

Cell death and differentiation

Gwenola Manic, Martina Musella, Francesca Corradi, Antonella Sistigu, Sara Vitale, Sara Soliman Abdel Rehim, Luca Mattiello, Eva Malacaria, Claudia Galassi, Michele Signore, Matteo Pallocca, Stefano Scalera, Frauke Goeman, Francesca De Nicola, Andrea Guarracino, Rosa Pennisi, Fabrizio Antonangeli, Francesca Sperati, Marta Baiocchi, Mauro Biffoni, Maurizio Fanciulli, Marcello Maugeri-Saccà, Annapaola Franchitto, Pietro Pichierri, Ruggero De Maria, Ilio Vitale

Affiliations

  1. IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Italy. [email protected].
  2. Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy. [email protected].
  3. Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
  4. Department of Biology, University of Rome "Tor Vergata", Rome, Italy.
  5. UOSD Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  6. IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Italy.
  7. Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  8. Mechanisms, Biomarkers and Models Unit, Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy.
  9. RPPA unit, Proteomics area, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
  10. UOSD Biostatistics, Bioinformatics and Clinical Trial Center, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  11. UOSD SAFU, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  12. Oncogenomic and Epigenetic Unit, Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  13. Department of Experimental Oncology, European Institute of Oncology (IEO), Milano, Italy.
  14. Department of Molecular Medicine, University "La Sapienza", Laboratory affiliated to Istituto Pasteur Italia, Rome, Italy.
  15. Institute of Molecular Biology and Pathology, National Research Council (CNR), Rome, Italy.
  16. UOSD Biostatistics, Bioinformatics and Clinical Trial Center, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
  17. Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  18. Division of Medical Oncology 2, IRCSS Regina Elena National Cancer Institute, Rome, Italy.
  19. Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. [email protected].
  20. Fondazione Policlinico Universitario "A. Gemelli" - IRCCS, Rome, Italy. [email protected].
  21. IIGM - Italian Institute for Genomic Medicine, c/o IRCSS, Candiolo, Italy. [email protected].
  22. Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy. [email protected].

PMID: 33531658 PMCID: PMC8257675 DOI: 10.1038/s41418-020-00733-4

Abstract

Cancer stem cells (CSCs) are tumor subpopulations driving disease development, progression, relapse and therapy resistance, and their targeting ensures tumor eradication. CSCs display heterogeneous replication stress (RS), but the functionality/relevance of the RS response (RSR) centered on the ATR-CHK1 axis is debated. Here, we show that the RSR is efficient in primary CSCs from colorectal cancer (CRC-SCs), and describe unique roles for PARP1 and MRE11/RAD51. First, we demonstrated that PARP1 is upregulated in CRC-SCs resistant to several replication poisons and RSR inhibitors (RSRi). In these cells, PARP1 modulates replication fork speed resulting in low constitutive RS. Second, we showed that MRE11 and RAD51 cooperate in the genoprotection and mitosis execution of PARP1-upregulated CRC-SCs. These roles represent therapeutic vulnerabilities for CSCs. Indeed, PARP1i sensitized CRC-SCs to ATRi/CHK1i, inducing replication catastrophe, and prevented the development of resistance to CHK1i. Also, MRE11i + RAD51i selectively killed PARP1-upregulated CRC-SCs via mitotic catastrophe. These results provide the rationale for biomarker-driven clinical trials in CRC using distinct RSRi combinations.

References

  1. Nat Struct Mol Biol. 2013 Mar;20(3):347-54 - PubMed
  2. Cell Stem Cell. 2014 Dec 4;15(6):692-705 - PubMed
  3. Cell Stem Cell. 2011 Oct 4;9(4):357-65 - PubMed
  4. Nature. 2005 Apr 14;434(7035):864-70 - PubMed
  5. Mol Cell. 2013 Mar 28;49(6):1097-107 - PubMed
  6. Gut. 2018 May;67(5):903-917 - PubMed
  7. Sci Transl Med. 2016 Oct 26;8(362):362ps17 - PubMed
  8. Cell Rep. 2018 Sep 4;24(10):2629-2642.e5 - PubMed
  9. Nature. 2018 Apr;556(7702):457-462 - PubMed
  10. Cell Stem Cell. 2020 Jan 2;26(1):48-63.e6 - PubMed
  11. Nat Biotechnol. 2011 Nov 13;29(12):1120-7 - PubMed
  12. Nat Commun. 2017 Oct 16;8(1):859 - PubMed
  13. Nature. 2018 Jul;559(7713):279-284 - PubMed
  14. Annu Rev Biochem. 2018 Jun 20;87:263-294 - PubMed
  15. Nature. 2006 Nov 30;444(7119):638-42 - PubMed
  16. Methods Enzymol. 2017;591:55-82 - PubMed
  17. Nature. 2016 Jul 20;535(7612):382-7 - PubMed
  18. Semin Cancer Biol. 2018 Dec;53:31-41 - PubMed
  19. EMBO Mol Med. 2017 Jul;9(7):869-879 - PubMed
  20. J Cell Biol. 2019 Apr 1;218(4):1096-1107 - PubMed
  21. Cell Stem Cell. 2014 Mar 6;14(3):342-56 - PubMed
  22. Nature. 2009 May 14;459(7244):262-5 - PubMed
  23. Nat Rev Cancer. 2018 Nov;18(11):669-680 - PubMed
  24. EMBO J. 2009 Sep 2;28(17):2601-15 - PubMed
  25. Stem Cells Transl Med. 2016 Apr;5(4):511-23 - PubMed
  26. Nat Commun. 2019 Sep 27;10(1):4410 - PubMed
  27. Science. 2013 Feb 1;339(6119):543-8 - PubMed
  28. Cell Stem Cell. 2019 Jan 3;24(1):41-53 - PubMed
  29. JCO Precis Oncol. 2017 Jul;2017: - PubMed
  30. Methods Mol Biol. 2013;965:93-120 - PubMed
  31. Nat Struct Mol Biol. 2012 Mar 04;19(4):417-23 - PubMed
  32. Nature. 2007 Jan 4;445(7123):111-5 - PubMed
  33. Nature. 2017 Mar 29;543(7647):676-680 - PubMed
  34. Nat Med. 2017 Oct 6;23(10):1124-1134 - PubMed
  35. Science. 2020 Apr 3;368(6486): - PubMed
  36. Cell. 2013 Nov 21;155(5):1088-103 - PubMed
  37. Mol Cell. 2017 May 4;66(3):306-319 - PubMed
  38. Nat Struct Mol Biol. 2010 Nov;17(11):1305-11 - PubMed
  39. Int Rev Cell Mol Biol. 2017;328:105-161 - PubMed
  40. Nat Rev Mol Cell Biol. 2017 Oct;18(10):622-636 - PubMed
  41. Nat Rev Cancer. 2015 May;15(5):276-89 - PubMed
  42. Nucleic Acids Res. 2010 Sep;38(16):e164 - PubMed
  43. Mol Cell. 2018 Jul 19;71(2):319-331.e3 - PubMed
  44. Annu Rev Pathol. 2016 May 23;11:47-76 - PubMed
  45. Nat Rev Clin Oncol. 2018 Feb;15(2):81-94 - PubMed
  46. Nat Rev Genet. 2017 Sep;18(9):535-550 - PubMed
  47. Nat Rev Clin Oncol. 2020 Jun;17(6):360-371 - PubMed
  48. Nat Commun. 2017 Oct 16;8(1):860 - PubMed
  49. Cancer Discov. 2018 May;8(5):537-555 - PubMed
  50. J Exp Med. 2017 Jul 3;214(7):2073-2088 - PubMed
  51. Cancer Discov. 2018 Nov;8(11):1404-1421 - PubMed
  52. Science. 2012 Aug 10;337(6095):730-5 - PubMed
  53. Genes Dev. 2008 Jun 1;22(11):1478-89 - PubMed
  54. Nucleic Acids Res. 2016 Jun 2;44(10):4745-62 - PubMed
  55. Nat Rev Mol Cell Biol. 2017 Oct;18(10):610-621 - PubMed
  56. Nat Rev Mol Cell Biol. 2015 Apr;16(4):207-20 - PubMed
  57. Cell Death Differ. 2011 May;18(5):841-52 - PubMed
  58. Cell Stem Cell. 2010 Jun 4;6(6):603-15 - PubMed
  59. J Cell Biol. 2020 Jan 6;219(1): - PubMed
  60. Mol Cell. 2010 Oct 22;40(2):179-204 - PubMed
  61. Cell. 2011 May 13;145(4):529-42 - PubMed
  62. Nature. 2017 May 11;545(7653):187-192 - PubMed
  63. Nature. 2006 Nov 30;444(7119):633-7 - PubMed
  64. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10079-E10088 - PubMed
  65. Nature. 2007 Jan 4;445(7123):106-10 - PubMed
  66. Cell Rep. 2018 May 15;23(7):2095-2106 - PubMed
  67. Trends Cell Biol. 2019 Jul;29(7):569-579 - PubMed
  68. Nat Rev Cancer. 2019 Feb;19(2):97-109 - PubMed
  69. Cell Stem Cell. 2019 Jan 3;24(1):54-64 - PubMed
  70. Nat Rev Mol Cell Biol. 2011 Jun;12(6):385-92 - PubMed
  71. J Cell Biol. 2015 Mar 2;208(5):563-79 - PubMed
  72. Nature. 2013 Feb 28;494(7438):492-496 - PubMed
  73. Cell Death Differ. 2018 Mar;25(3):486-541 - PubMed
  74. Bioinformatics. 2016 Sep 15;32(18):2866-8 - PubMed
  75. Nat Cell Biol. 2014 Jan;16(1):2-9 - PubMed
  76. Nucleic Acids Res. 2019 Jul 2;47(W1):W43-W51 - PubMed
  77. Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067 - PubMed
  78. Cancer Res. 2018 Sep 1;78(17):5060-5071 - PubMed
  79. Nat Commun. 2019 Mar 29;10(1):1412 - PubMed
  80. PLoS Genet. 2018 Dec 26;14(12):e1007752 - PubMed

Publication Types

Grant support